Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Transthyretin Amyloidosis in Hypertrophic Cardiomyopathy

NCT01623245 is registered in ClinicalTrials.gov with Thibaud Damy as lead sponsor.

NCT NCT01623245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01623245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Transthyretin Amyloidosis in Hypertrophic Cardiomyopathy
Lead sponsor
Thibaud Damy
Phase
Observational
Overall status
Completed
Start date
June 30, 2012
Completion date
December 31, 2014
Enrollment
294 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis in transthyretin (ttr), cardiac amyloidosis, hypertrophic cardiomyopathy (hcm)